Browse by Medical Category
Accepting New Patients
Dr. Misra is the Fritz Bradley Talbot and Nathan Bill Talbot Professor of Pediatrics at Harvard Medical School, Chief of the Division of Pediatric Endocrinology at MassGeneral Hospital for Children, and Director of the Pediatric Endocrine-Sports Endocrine-Neuroendocrine Laboratory at Massachusetts General Hospital. Learn more about Dr. Misra
Go To Programs
MassGeneral Hospital for Children
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Dr. Misra completed her fellowship in Pediatric Endocrinology at Mass General Hospital (MGH) and Masters in Public Health at the Harvard School of Public Health. She is Chief of the Division of Pediatric Endocrinology at MGHfC, Associate Director of the Harvard Catalyst Clinical Research Center (MGH) and Director of the Pediatric Endocrine-Sports Endocrine-Neuroendocrine Lab (MGH). Dr. Misra has chaired the Drugs and Therapeutics Committee, the Steering Committee for the Fellow Spring Retreat, and the Research Affairs Council of the Pediatric Endocrine Society (PES). She is an ex-Director and now President Elect of the PES, and on the Subboard of Endocrinology for the ABP. Dr. Misra has received the John Haddad Young Investigator Award (AIMM-ASBMR), the Janet W. McArthur Award (Women in Endocrinology), the Claflin Distinguished Scholar Award (MGH) and the Rita M. Kelley, MD, Fellowship (MGH). She is an ex-NIH study section member. Dr. Misra specializes in neuroendocrine and bone disorders. She is internationally known for her work on neuroendocrine, metabolic and bone complications of disorders that span the weight spectrum from anorexia nervosa to obesity, as well as autism spectrum disorders, and her work has led to major strides in the clinical management of these conditions. Given her work on reproductive and bone dysfunction in the female athlete, she has been identified as an expert on endocrine issues in athletes by the Female Athlete Triad Coalition. Dr. Misra has a special clinical interest in pituitary disorders, and her panel includes children with some of the most complex pituitary tumors. She is associated with the multidisciplinary Neuroendocrine Clinical Center at MGH, and is often asked to provide second opinions on complex pituitary cases. In addition, Dr. Misra sees children with growth and puberty disorders, reproductive, adrenal and thyroid disorders, and children with diabetes.
View my most recent research
Research within the Pediatric Endocrine-Neuroendocrine-Sports Endocrine Lab aims to further knowledge about endocrine, bone, neurocognitive and neuropsychiatric outcomes in athletes, girls with low-weight eating disorders, teenagers and young adults undergoing bariatric surgery, and children with autism spectrum disorders.
Some ongoing studies include the following:
Learn more about research at the Pediatric Endocrine Program and Diabetes Center.
View my most recent publications at PubMed
Selected Original Articles (from over 100)
1. Misra M, Katzman DK, Miller KK, Mendes N, Snelgrove D, Russell M, Goldstein MA, Ebrahimi S, Clauss L, Weigel T, Mickley D, Schoenfeld D, Herzog DB, Klibanski A. Physiologic Estrogen Replacement Increases Bone Density in Adolescent Girls with Anorexia Nervosa. J Bone Miner Res 2011;26:2430-8
2. Ackerman KE, Nazem T, Chapko C, Russell M, Mendes N, Taylor AP, Bouxsein ML, Misra M. Bone Microarchitecture is Impaired in Adolescent Amenorrheic Athletes Compared with Eumenorrheic Athletes and Non-Athletic Controls. J Clin Endocrinol Metab 2011;96:3123-33.
Selected Reviews (from over 50)
1. Misra M, Pacaud D, Petryk A, Collett-Solberg P, Kappy M, on behalf of the D&T Committee of the LWPES. Vitamin D Deficiency in Children and its Management: Review of Current Knowledge and Recommendations. Pediatrics 2008; 122: 398-417.
2. Misra M. Effects of Hypogonadism on Bone Metabolism in Adolescent and Young Adult Women. Nature Reviews Endocrinology 2012;8(7):395-4043. Misra M, Klibanski A. Endocrine Consequences of Anorexia Nervosa. The Lancet Diabetes and Endocrinology. In Press
1. Smith E, Loeffler J, Misra M, Pomerantz S, Stemmer-Rachamimov A, Post M. Case records of the MGH: Case 37-2008. A 17-year-old boy with a pituitary tumor and skull abnormalities. New Eng J Med 2008;359:2367-77
2. Misra M, Parangi S, Ross D, Sadow P, Shailam R. Case records of the MGH: Case 38-2010: a 13-year-old girl with an enlarging neck mass. New Eng J Med 2010;363:2445-54
New research from MassGeneral Hospital for Children shows the benefits of estrogen replacement therapy for improving physiological and psychological outcomes in young females with anorexia nervosa.
Madhusmita Misra, MD, MPH, chief of Pediatric Endocrinology at MGHfC, has been elected to serve on the Board of Directors of the Pediatric Endocrine Society from 2016-2016.
Madhusmita Misra, MD, MPH, has been named the chief of Pediatric Endocrinology at MassGeneral Hospital for Children (MGHfC), effective July 1, 2015.
Young female athletes who have stopped menstruating have a weakening in the quality of their bone structure that may predispose them to breaking a bone, despite getting plenty of weight-bearing exercise, a new study finds.
Estrogen therapy improves low bone density in teenage girls with anorexia nervosa when given as a patch or at an oral dose close to the form or amount the body makes naturally.
Teenager Dipika Daryanani is combating Cushing's disease with innovative treatment and her multidisciplinary care team at MassGeneral Hospital for Children.
According to a new study accepted for publication in the Journal of Clinical Endocrinology & Metabolism, obese teenage girls with a greater ratio of visceral fat (fat around internal organs) to subcutaneous fat (fat found just beneath the skin) are likely to have lower bone density than peers with a lower ratio of visceral to subcutaneous fat.
Back to Top